Epigenetic Reactivation of Lineage Differentiation to Target Leukemia

Area of Science:

• Molecular Biology
• Cancer Research
• Hematology

Background:

• Chromatin regulation is crucial for gene expression and cancer.
• The roles of chromatin adaptors, like TRIM28, are not fully understood in cancer.
• Acute leukemia involves dysregulated gene expression and impaired cell differentiation.

Purpose of the Study:

• To investigate the function of chromatin adaptors in acute leukemia.
• To identify dependencies and therapeutic targets in acute myeloid leukemia.
• To develop a small-molecule inhibitor for TRIM28.

Main Methods:

• Focused CRISPR screening to identify TRIM28 dependency.
• Integrative transcriptomic and chromatin profiling.
• Development and testing of a selective small-molecule TRIM28 inhibitor.

Main Results:

• TRIM28 depletion impairs leukemia cell proliferation and activates neutrophil differentiation.
• TRIM28 acts as a co-repressor of neutrophil-associated genes.
• Loss of TRIM28 induces terminal differentiation into mature neutrophil-like cells with reduced leukemic potential.
• The developed TRIM28 inhibitor shows anti-leukemia activity and induces differentiation.

Conclusions:

• TRIM28 is a critical regulator of myeloid cell fate in acute leukemia.
• Targeting TRIM28 with small-molecule inhibitors promotes differentiation and has therapeutic potential.
• TRIM28 inhibition offers a novel pro-differentiation strategy for acute leukemia treatment.